These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9158079)

  • 21. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
    Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
    Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
    Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound measurements of proximal phalanges in Polish early postmenopausal women.
    Pluskiewicz W; Drozdzowska B
    Osteoporos Int; 1998; 8(6):578-83. PubMed ID: 10326064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study.
    Yang TS; Chen YJ; Liang WH; Chang CY; Tai LC; Chang SP; Ng HT
    J Chin Med Assoc; 2007 May; 70(5):200-6. PubMed ID: 17524997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative ultrasound at the phalanxes discriminates osteoporotic women with vertebral but not with hip fracture.
    Gnudi S; Ripamonti C
    Ultrasound Med Biol; 2004 Mar; 30(3):357-61. PubMed ID: 15063517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT.
    de Aloysio D; Gambacciani M; Altieri P; Ciaponi M; Ventura V; Mura M; Genazzani AR; Bottiglioni F
    Gynecol Endocrinol; 1997 Aug; 11(4):289-93. PubMed ID: 9272427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QUS in monitoring raloxifene and estrogen-progestogens: a 4-year longitudinal study.
    Agostinelli D; de Terlizzi F
    Ultrasound Med Biol; 2007 Aug; 33(8):1184-90. PubMed ID: 17467152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss.
    Hillard TC; Whitcroft SJ; Marsh MS; Ellerington MC; Lees B; Whitehead MI; Stevenson JC
    Osteoporos Int; 1994 Nov; 4(6):341-8. PubMed ID: 7696830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
    Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
    Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study.
    Mizunuma H; Okano H; Soda M; Kagami I; Miyamoto S; Tokizawa T; Honjo S; Ibuki Y
    Maturitas; 1997 May; 27(1):69-76. PubMed ID: 9158080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ultrasound (QUS) at the calcaneus and hand phalanges in Polish healthy postmenopausal women.
    Pluskiewicz W; Drozdzowska B
    Ultrasound Med Biol; 2001 Mar; 27(3):373-7. PubMed ID: 11369123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women.
    Stomati M; Bersi C; Rubino S; Palumbo M; Comitini G; Genazzani AD; Santuz M; Petraglia F; Genazzani AR
    Maturitas; 1997 Dec; 28(2):127-35. PubMed ID: 9522320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
    Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
    Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
    Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
    Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
    Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.
    Delmas PD; Pornel B; Felsenberg D; Garnero P; Hardy P; Pilate C; Dain MP
    Bone; 1999 May; 24(5):517-23. PubMed ID: 10321913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ossein-hydroxyapatite compounds for preventing postmenopausal bone loss. Coadjuvant use with hormone replacement therapy.
    Castelo-Branco C; Martínez de Osaba MJ; Pons F; Casals E; Sanjuán A; Vicente JJ; Vanrell JA
    J Reprod Med; 1999 Mar; 44(3):241-6. PubMed ID: 10202741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot C
    Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.